Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide

Endocrinology
M F WalshJ R Sowers

Abstract

Although most insulin-like growth factor I (IGF-I) in the circulation is generated by the liver, the hormone is also produced locally by the vasculature, suggesting its potential importance in regulation of regional blood flow. Accordingly, we studied the effects of in vivo exposure to IGF-I (5.1 nmol, i.v.) as well as in vitro incubation (100 nM) on endothelium-intact rat tail artery contractile responses to KCl and norepinephrine (NE). Systemic administration of IGF-I resulted in transient lowering of blood pressure, with maximal reduction occurring at 15 min and a return to baseline by 60 min. Maximal contractility of rings removed from animals 90 min after a bolus injection of IGF-I, when blood pressure had returned to normal, was significantly reduced for both KCl (58%) and NE (51%) without a change in sensitivity. Similar data were obtained when rings from untreated animals were preincubated in vitro for 90 min; maximal contractility in response to KCl was decreased by 31% and that to NE by 22%. L-Nitroarginine methyl ester, an inhibitor of nitric oxide (NO) production, administered in vivo before IGF-I or added to the bath buffer reversed the attenuation. The nearly identical in vivo and in vitro results suggest that the...Continue Reading

Citations

Nov 15, 2012·Journal of Translational Medicine·Juan E Puche, Inma Castilla-Cortázar
Jul 11, 2009·Endocrine Reviews·Claes OhlssonJohan Svensson
Nov 20, 1998·The Journal of Pharmacy and Pharmacology·D W LaightE E Anggård
May 7, 2004·Current Hypertension Reports·Fadi El-AtatJames R Sowers
Nov 26, 2010·Journal of Physiology and Biochemistry·Emina SudarEsma R Isenovic
May 16, 2006·Vascular Pharmacology·Vladimir BobekKatarina Kolostova
Jan 17, 2012·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Masanori OhtaHiroshi Yamato
Jun 29, 2014·Endocrine·Jörgen IsgaardAntonio Cittadini
Jan 27, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Eric D Rabinovsky, Ruxandra Draghia-Akli
Nov 26, 1999·Clinical and Experimental Hypertension : CHE·Z DuanmuJ C Dunbar
Jan 19, 2018·International Journal of Molecular Sciences·Diego CaicedoJesús Devesa
Jan 26, 2018·Journal of Hypertension·Alon BotzerRon Unger
May 10, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A-L YangS-D Lee
May 21, 2004·American Journal of Physiology. Cell Physiology·Yuan WeiWen-Hui Wang
Oct 25, 2016·Clinical Medicine Insights. Endocrinology and Diabetes·Jesús DevesaPablo Devesa
Dec 17, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Federico E Rey, Patrick J Pagano
Mar 4, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·J A JanssenS W Lamberts
Apr 15, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·S Schuler-Luttmann von Eckardstein A
Apr 22, 2008·International Journal of Clinical Practice·I KartalF Alagöl
Jan 7, 2010·Current Opinion in Nephrology and Hypertension·Alvaro YogiRhian M Touyz
Mar 25, 2000·Drugs & Aging·E ArvatE Ghigo
Sep 17, 2008·Expert Review of Cardiovascular Therapy·Afroze AbbasMark T Kearney
Jul 28, 2009·Clinical Science·Richard M CubbonStephen B Wheatcroft
Jan 22, 2005·Journal of Hypertension·Roland W McCallumAnna F Dominiczak
Jul 21, 2016·American Journal of Respiratory Cell and Molecular Biology·Miranda SunJ Usha Raj
Nov 7, 2019·Current Pharmaceutical Design·Milan ObradovicEsma R Isenovic
Jul 14, 2000·American Journal of Physiology. Endocrinology and Metabolism·C L OltmanK C Dellsperger
Apr 10, 2004·American Journal of Physiology. Heart and Circulatory Physiology·James R Sowers
Mar 21, 1998·Clinical and Experimental Hypertension : CHE·G Pete, J C Dunbar
Oct 25, 2000·American Journal of Physiology. Heart and Circulatory Physiology·M E CifuentesP J Pagano
Feb 24, 2001·Clinical Endocrinology·A ColaoG Lombardi
Oct 18, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Tsuneo Kobayashi, Katsuo Kamata
Jun 26, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Shawna A CooperJames R Sowers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.